Loading…

Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival

Background and aim Chemotactic cytokines play a role in angiogenesis and attraction of immune cells. However, their contribution to tumor formation remains incompletely understood. In a previous transcriptome study, we identified a family of structurally related chemokines of the CXC-family to be sp...

Full description

Saved in:
Bibliographic Details
Published in:International journal of colorectal disease 2010-05, Vol.25 (5), p.573-581
Main Authors: Doll, Dietrich, Keller, Larissa, Maak, Matthias, Boulesteix, Anne-Laure, Siewert, Jörg R, Holzmann, Bernhard, Janssen, Klaus-Peter
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c523t-1535e60fb7810aaa7d682236868b1fa6be008695625178332ecfda3ae42d15fb3
cites cdi_FETCH-LOGICAL-c523t-1535e60fb7810aaa7d682236868b1fa6be008695625178332ecfda3ae42d15fb3
container_end_page 581
container_issue 5
container_start_page 573
container_title International journal of colorectal disease
container_volume 25
creator Doll, Dietrich
Keller, Larissa
Maak, Matthias
Boulesteix, Anne-Laure
Siewert, Jörg R
Holzmann, Bernhard
Janssen, Klaus-Peter
description Background and aim Chemotactic cytokines play a role in angiogenesis and attraction of immune cells. However, their contribution to tumor formation remains incompletely understood. In a previous transcriptome study, we identified a family of structurally related chemokines of the CXC-family to be specifically up-regulated in colorectal cancer. The aim of the present study was to investigate the regulation of their expression in colon cancer cells and to test the hypothesis that altered CXC-chemokine expression is related to critical clinical parameters, such as survival or metastasis formation. Materials and methods Expression levels of interleukin-8 (CXCL-8) and growth-related oncogenes 2 and 3 (GRO-2/CXCL-2 and GRO-3/CXCL-3) were quantified using qRT-PCR in 97 patients with completely resected colon carcinoma and correlated with clinical parameters. Moreover, 16 samples of normal mucosa, nine samples of benign adenoma, and 11 samples of liver metastasis were analyzed. Next, the regulation of chemokine expression in response to various stimuli was tested in colon cancer cell lines (HT29, HCT116, CaCO2). Results Expression of GRO-2, GRO-3, and IL-8 was significantly increased in colon cancer as compared to normal colon tissue. Expression of GRO-2 and GRO-3 was already enhanced in premalignant adenomas, and GRO-3 was significantly down-regulated in liver metastasis as compared to the primary tumor. Importantly, expression of GRO-3 was significantly higher in patients with local versus systemic disease. Moreover, IL-8 expression was significantly associated to overall post-operative survival. Finally, all chemokines were strongly induced by IL-1alpha in the colon cancer cell lines tested, indicating a potential link to inflammatory processes. Conclusion In accordance with earlier findings, we report here a significantly increased expression of GRO-2, GRO-3, and IL-8 in colon carcinoma as compared to normal tissue. Furthermore, GRO-3 was related to metastasis formation, and IL-8 was associated with survival, suggesting a potential predictive power of these markers.
doi_str_mv 10.1007/s00384-010-0901-1
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_745700484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A714486991</galeid><sourcerecordid>A714486991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-1535e60fb7810aaa7d682236868b1fa6be008695625178332ecfda3ae42d15fb3</originalsourceid><addsrcrecordid>eNqFkttu1DAQhiMEotuFB-AGIhDipinjQxznsipQkCpVAnptzTrjrUsOi51U9CF4Z7ybhQqEQHNhjef7Zzzyn2VPGBwzgOp1BBBaFsCggBpYwe5lCyYFLxhX_H62AFbVBatLfZAdxngNKVeVfJgdcGCKS84X2fc33jkK1I8e25y-bQLF6Ic-H1w-XlFur6gbvvieYn728aLgR7tDHOXYN7nvRwotTale6JTldmiT1GJvKeyI1MKH3HcbtGOeSh2NGEccvc0bHwkj7bA4hRt_g-2j7IHDNtLj_bnMLt-9_Xz6vji_OPtwenJe2JKLsWClKEmBW1WaASJWjdKcC6WVXjGHakUAWtWl4iWrtBCcrGtQIEnesNKtxDJ7NffdhOHrRHE0nY-W2hZ7GqZoKllWAFLL_5NCCCl0imX2_A_yephCn9YwnKkSeF3XCXoxQ2tsyfjeDWNAu21pTiomZXp1zRJ1_BcqRUOdt0NPzqf73wRsFtgwxBjImU3wHYZbw8BsrWJmq5hkFbO1itlqnu7fO606an4pfnojAS_3AEaLrQvpW32847gCVuvtTnzmYir1awp3i_9r-rNZ5HAwuA6p8eWnNFoA0xyEAvED3hLb9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216502999</pqid></control><display><type>article</type><title>Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival</title><source>Springer Nature</source><creator>Doll, Dietrich ; Keller, Larissa ; Maak, Matthias ; Boulesteix, Anne-Laure ; Siewert, Jörg R ; Holzmann, Bernhard ; Janssen, Klaus-Peter</creator><creatorcontrib>Doll, Dietrich ; Keller, Larissa ; Maak, Matthias ; Boulesteix, Anne-Laure ; Siewert, Jörg R ; Holzmann, Bernhard ; Janssen, Klaus-Peter</creatorcontrib><description>Background and aim Chemotactic cytokines play a role in angiogenesis and attraction of immune cells. However, their contribution to tumor formation remains incompletely understood. In a previous transcriptome study, we identified a family of structurally related chemokines of the CXC-family to be specifically up-regulated in colorectal cancer. The aim of the present study was to investigate the regulation of their expression in colon cancer cells and to test the hypothesis that altered CXC-chemokine expression is related to critical clinical parameters, such as survival or metastasis formation. Materials and methods Expression levels of interleukin-8 (CXCL-8) and growth-related oncogenes 2 and 3 (GRO-2/CXCL-2 and GRO-3/CXCL-3) were quantified using qRT-PCR in 97 patients with completely resected colon carcinoma and correlated with clinical parameters. Moreover, 16 samples of normal mucosa, nine samples of benign adenoma, and 11 samples of liver metastasis were analyzed. Next, the regulation of chemokine expression in response to various stimuli was tested in colon cancer cell lines (HT29, HCT116, CaCO2). Results Expression of GRO-2, GRO-3, and IL-8 was significantly increased in colon cancer as compared to normal colon tissue. Expression of GRO-2 and GRO-3 was already enhanced in premalignant adenomas, and GRO-3 was significantly down-regulated in liver metastasis as compared to the primary tumor. Importantly, expression of GRO-3 was significantly higher in patients with local versus systemic disease. Moreover, IL-8 expression was significantly associated to overall post-operative survival. Finally, all chemokines were strongly induced by IL-1alpha in the colon cancer cell lines tested, indicating a potential link to inflammatory processes. Conclusion In accordance with earlier findings, we report here a significantly increased expression of GRO-2, GRO-3, and IL-8 in colon carcinoma as compared to normal tissue. Furthermore, GRO-3 was related to metastasis formation, and IL-8 was associated with survival, suggesting a potential predictive power of these markers.</description><identifier>ISSN: 0179-1958</identifier><identifier>EISSN: 1432-1262</identifier><identifier>DOI: 10.1007/s00384-010-0901-1</identifier><identifier>PMID: 20162422</identifier><identifier>CODEN: IJCDE6</identifier><language>eng</language><publisher>Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag</publisher><subject>Analysis ; Biological and medical sciences ; Cell Line, Tumor ; Chemokine CXCL2 - genetics ; Chemokine CXCL2 - metabolism ; Chemokines, CXC - genetics ; Chemokines, CXC - metabolism ; Colon cancer ; Colonic Neoplasms - genetics ; Colonic Neoplasms - pathology ; Female ; Gastroenterology ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Hepatology ; Humans ; Interleukin-8 - genetics ; Interleukin-8 - metabolism ; Interleukins ; Internal Medicine ; Kaplan-Meier Estimate ; Liver ; Liver Neoplasms - secondary ; Male ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Metastasis ; Middle Aged ; Neoplasm Staging ; Original Article ; Proctology ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Surgery ; Survival Analysis ; Tumors</subject><ispartof>International journal of colorectal disease, 2010-05, Vol.25 (5), p.573-581</ispartof><rights>Springer-Verlag 2010</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2010 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-1535e60fb7810aaa7d682236868b1fa6be008695625178332ecfda3ae42d15fb3</citedby><cites>FETCH-LOGICAL-c523t-1535e60fb7810aaa7d682236868b1fa6be008695625178332ecfda3ae42d15fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22601989$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20162422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Doll, Dietrich</creatorcontrib><creatorcontrib>Keller, Larissa</creatorcontrib><creatorcontrib>Maak, Matthias</creatorcontrib><creatorcontrib>Boulesteix, Anne-Laure</creatorcontrib><creatorcontrib>Siewert, Jörg R</creatorcontrib><creatorcontrib>Holzmann, Bernhard</creatorcontrib><creatorcontrib>Janssen, Klaus-Peter</creatorcontrib><title>Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival</title><title>International journal of colorectal disease</title><addtitle>Int J Colorectal Dis</addtitle><addtitle>Int J Colorectal Dis</addtitle><description>Background and aim Chemotactic cytokines play a role in angiogenesis and attraction of immune cells. However, their contribution to tumor formation remains incompletely understood. In a previous transcriptome study, we identified a family of structurally related chemokines of the CXC-family to be specifically up-regulated in colorectal cancer. The aim of the present study was to investigate the regulation of their expression in colon cancer cells and to test the hypothesis that altered CXC-chemokine expression is related to critical clinical parameters, such as survival or metastasis formation. Materials and methods Expression levels of interleukin-8 (CXCL-8) and growth-related oncogenes 2 and 3 (GRO-2/CXCL-2 and GRO-3/CXCL-3) were quantified using qRT-PCR in 97 patients with completely resected colon carcinoma and correlated with clinical parameters. Moreover, 16 samples of normal mucosa, nine samples of benign adenoma, and 11 samples of liver metastasis were analyzed. Next, the regulation of chemokine expression in response to various stimuli was tested in colon cancer cell lines (HT29, HCT116, CaCO2). Results Expression of GRO-2, GRO-3, and IL-8 was significantly increased in colon cancer as compared to normal colon tissue. Expression of GRO-2 and GRO-3 was already enhanced in premalignant adenomas, and GRO-3 was significantly down-regulated in liver metastasis as compared to the primary tumor. Importantly, expression of GRO-3 was significantly higher in patients with local versus systemic disease. Moreover, IL-8 expression was significantly associated to overall post-operative survival. Finally, all chemokines were strongly induced by IL-1alpha in the colon cancer cell lines tested, indicating a potential link to inflammatory processes. Conclusion In accordance with earlier findings, we report here a significantly increased expression of GRO-2, GRO-3, and IL-8 in colon carcinoma as compared to normal tissue. Furthermore, GRO-3 was related to metastasis formation, and IL-8 was associated with survival, suggesting a potential predictive power of these markers.</description><subject>Analysis</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>Chemokine CXCL2 - genetics</subject><subject>Chemokine CXCL2 - metabolism</subject><subject>Chemokines, CXC - genetics</subject><subject>Chemokines, CXC - metabolism</subject><subject>Colon cancer</subject><subject>Colonic Neoplasms - genetics</subject><subject>Colonic Neoplasms - pathology</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Expression Profiling</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Interleukin-8 - genetics</subject><subject>Interleukin-8 - metabolism</subject><subject>Interleukins</subject><subject>Internal Medicine</subject><subject>Kaplan-Meier Estimate</subject><subject>Liver</subject><subject>Liver Neoplasms - secondary</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Original Article</subject><subject>Proctology</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Surgery</subject><subject>Survival Analysis</subject><subject>Tumors</subject><issn>0179-1958</issn><issn>1432-1262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkttu1DAQhiMEotuFB-AGIhDipinjQxznsipQkCpVAnptzTrjrUsOi51U9CF4Z7ybhQqEQHNhjef7Zzzyn2VPGBwzgOp1BBBaFsCggBpYwe5lCyYFLxhX_H62AFbVBatLfZAdxngNKVeVfJgdcGCKS84X2fc33jkK1I8e25y-bQLF6Ic-H1w-XlFur6gbvvieYn728aLgR7tDHOXYN7nvRwotTale6JTldmiT1GJvKeyI1MKH3HcbtGOeSh2NGEccvc0bHwkj7bA4hRt_g-2j7IHDNtLj_bnMLt-9_Xz6vji_OPtwenJe2JKLsWClKEmBW1WaASJWjdKcC6WVXjGHakUAWtWl4iWrtBCcrGtQIEnesNKtxDJ7NffdhOHrRHE0nY-W2hZ7GqZoKllWAFLL_5NCCCl0imX2_A_yephCn9YwnKkSeF3XCXoxQ2tsyfjeDWNAu21pTiomZXp1zRJ1_BcqRUOdt0NPzqf73wRsFtgwxBjImU3wHYZbw8BsrWJmq5hkFbO1itlqnu7fO606an4pfnojAS_3AEaLrQvpW32847gCVuvtTnzmYir1awp3i_9r-rNZ5HAwuA6p8eWnNFoA0xyEAvED3hLb9A</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Doll, Dietrich</creator><creator>Keller, Larissa</creator><creator>Maak, Matthias</creator><creator>Boulesteix, Anne-Laure</creator><creator>Siewert, Jörg R</creator><creator>Holzmann, Bernhard</creator><creator>Janssen, Klaus-Peter</creator><general>Berlin/Heidelberg : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100501</creationdate><title>Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival</title><author>Doll, Dietrich ; Keller, Larissa ; Maak, Matthias ; Boulesteix, Anne-Laure ; Siewert, Jörg R ; Holzmann, Bernhard ; Janssen, Klaus-Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-1535e60fb7810aaa7d682236868b1fa6be008695625178332ecfda3ae42d15fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Analysis</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>Chemokine CXCL2 - genetics</topic><topic>Chemokine CXCL2 - metabolism</topic><topic>Chemokines, CXC - genetics</topic><topic>Chemokines, CXC - metabolism</topic><topic>Colon cancer</topic><topic>Colonic Neoplasms - genetics</topic><topic>Colonic Neoplasms - pathology</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Expression Profiling</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Interleukin-8 - genetics</topic><topic>Interleukin-8 - metabolism</topic><topic>Interleukins</topic><topic>Internal Medicine</topic><topic>Kaplan-Meier Estimate</topic><topic>Liver</topic><topic>Liver Neoplasms - secondary</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Original Article</topic><topic>Proctology</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Surgery</topic><topic>Survival Analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Doll, Dietrich</creatorcontrib><creatorcontrib>Keller, Larissa</creatorcontrib><creatorcontrib>Maak, Matthias</creatorcontrib><creatorcontrib>Boulesteix, Anne-Laure</creatorcontrib><creatorcontrib>Siewert, Jörg R</creatorcontrib><creatorcontrib>Holzmann, Bernhard</creatorcontrib><creatorcontrib>Janssen, Klaus-Peter</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of colorectal disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Doll, Dietrich</au><au>Keller, Larissa</au><au>Maak, Matthias</au><au>Boulesteix, Anne-Laure</au><au>Siewert, Jörg R</au><au>Holzmann, Bernhard</au><au>Janssen, Klaus-Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival</atitle><jtitle>International journal of colorectal disease</jtitle><stitle>Int J Colorectal Dis</stitle><addtitle>Int J Colorectal Dis</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>25</volume><issue>5</issue><spage>573</spage><epage>581</epage><pages>573-581</pages><issn>0179-1958</issn><eissn>1432-1262</eissn><coden>IJCDE6</coden><abstract>Background and aim Chemotactic cytokines play a role in angiogenesis and attraction of immune cells. However, their contribution to tumor formation remains incompletely understood. In a previous transcriptome study, we identified a family of structurally related chemokines of the CXC-family to be specifically up-regulated in colorectal cancer. The aim of the present study was to investigate the regulation of their expression in colon cancer cells and to test the hypothesis that altered CXC-chemokine expression is related to critical clinical parameters, such as survival or metastasis formation. Materials and methods Expression levels of interleukin-8 (CXCL-8) and growth-related oncogenes 2 and 3 (GRO-2/CXCL-2 and GRO-3/CXCL-3) were quantified using qRT-PCR in 97 patients with completely resected colon carcinoma and correlated with clinical parameters. Moreover, 16 samples of normal mucosa, nine samples of benign adenoma, and 11 samples of liver metastasis were analyzed. Next, the regulation of chemokine expression in response to various stimuli was tested in colon cancer cell lines (HT29, HCT116, CaCO2). Results Expression of GRO-2, GRO-3, and IL-8 was significantly increased in colon cancer as compared to normal colon tissue. Expression of GRO-2 and GRO-3 was already enhanced in premalignant adenomas, and GRO-3 was significantly down-regulated in liver metastasis as compared to the primary tumor. Importantly, expression of GRO-3 was significantly higher in patients with local versus systemic disease. Moreover, IL-8 expression was significantly associated to overall post-operative survival. Finally, all chemokines were strongly induced by IL-1alpha in the colon cancer cell lines tested, indicating a potential link to inflammatory processes. Conclusion In accordance with earlier findings, we report here a significantly increased expression of GRO-2, GRO-3, and IL-8 in colon carcinoma as compared to normal tissue. Furthermore, GRO-3 was related to metastasis formation, and IL-8 was associated with survival, suggesting a potential predictive power of these markers.</abstract><cop>Berlin/Heidelberg</cop><pub>Berlin/Heidelberg : Springer-Verlag</pub><pmid>20162422</pmid><doi>10.1007/s00384-010-0901-1</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0179-1958
ispartof International journal of colorectal disease, 2010-05, Vol.25 (5), p.573-581
issn 0179-1958
1432-1262
language eng
recordid cdi_proquest_miscellaneous_745700484
source Springer Nature
subjects Analysis
Biological and medical sciences
Cell Line, Tumor
Chemokine CXCL2 - genetics
Chemokine CXCL2 - metabolism
Chemokines, CXC - genetics
Chemokines, CXC - metabolism
Colon cancer
Colonic Neoplasms - genetics
Colonic Neoplasms - pathology
Female
Gastroenterology
Gastroenterology. Liver. Pancreas. Abdomen
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Hepatology
Humans
Interleukin-8 - genetics
Interleukin-8 - metabolism
Interleukins
Internal Medicine
Kaplan-Meier Estimate
Liver
Liver Neoplasms - secondary
Male
Medical sciences
Medicine
Medicine & Public Health
Metastasis
Middle Aged
Neoplasm Staging
Original Article
Proctology
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Surgery
Survival Analysis
Tumors
title Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A20%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20expression%20of%20the%20chemokines%20GRO-2,%20GRO-3,%20and%20interleukin-8%20in%20colon%20cancer%20and%20their%20impact%20on%20metastatic%20disease%20and%20survival&rft.jtitle=International%20journal%20of%20colorectal%20disease&rft.au=Doll,%20Dietrich&rft.date=2010-05-01&rft.volume=25&rft.issue=5&rft.spage=573&rft.epage=581&rft.pages=573-581&rft.issn=0179-1958&rft.eissn=1432-1262&rft.coden=IJCDE6&rft_id=info:doi/10.1007/s00384-010-0901-1&rft_dat=%3Cgale_proqu%3EA714486991%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c523t-1535e60fb7810aaa7d682236868b1fa6be008695625178332ecfda3ae42d15fb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=216502999&rft_id=info:pmid/20162422&rft_galeid=A714486991&rfr_iscdi=true